New Key Statistics Module, Z-Score and F-Score
NAS:CRSP Key Ratios
Market Cap $ M | 4,146.84 |
Enterprise Value $ M | 3,877.22 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.09 |
Price/Sales | 19.40 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 200.00 |
EPS (TTM) $ | -3.20 |
Beneish M-Score | 2.35 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.93 |
EV-to-EBITDA | -11.57 |
PEG | -- |
Shares Outstanding M | 85.17 |
Net Margin (%) | -132.90 |
Operating Margin % | -177.34 |
Pre-tax Margin (%) | -131.57 |
Quick Ratio | 15.73 |
Current Ratio | 15.73 |
ROA % (ttm) | -11.77 |
ROE % (ttm) | -14.00 |
ROIC % (ttm) | -53.65 |
Dividend Yield % | -- |
Altman Z-Score | 6.87 |
CRSP Number of Guru Trades
CRSP Volume of Guru Trades
Gurus Latest Trades with NAS:CRSP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CRSP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CRISPR Therapeutics AG Insider Transactions
No Available Data
News about NAS:CRSP
Total 0- 1